ENTA beat EPS expectations by 8.52%
May 12, 2025, 10:31 PM
0.00%
What does ENTA do
Enanta Pharmaceuticals, based in Watertown, Massachusetts, focuses on developing small molecule drugs for viral infections and liver diseases, including treatments for RSV and hepatitis C. The company went public in March 2013 and employs 145 people.
Enanta Pharmaceuticals (ENTA) reported a positive EPS surprise in its most recent quarterly earnings. For the most recent quarter, Enanta Pharmaceuticals's actual EPS was -$1.06, beating the estimate of -$1.16 per share, resulting in a 8.52% surprise.
📡️ Health Care
Earnings Surprise
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.